Cancer biomarkers in clinical practice

Cancer is the second cause of mortality worldwide, after cardiovascular diseases. Increased prevalence of cancer but also the fact that, most often, the diagnosis is established at a moment when therapeutic resources are already limited, constituted the premise for researching and developing indicators of disease or evolution. With the present article we aim to perform a brief review of the biomarkers currently in use in clinical practice for the diagnosis, prognosis and therapy of neoplasms, as well as those that are under evaluation.